Research Associate I/II ~ Bioconjugation

Sorry, this job was removed at 09:01 p.m. (CST) on Monday, Nov 18, 2024
Be an Early Applicant
Redwood City, CA
In-Office
60K-85K Annually
Biotech
The Role

Who We Are

Bolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISACs), a new class of immuno-oncology therapeutics. This is a unique opportunity to join and build, with like-minded colleagues, a company that will transform the lives of individuals with cancer.


At Bolt Biotherapeutics, we are seeking for highly motivated Research Associate to join our research bioconjugation team. The primary responsibility of the successful candidate is to perform variety of antibody conjugation chemistries and techniques to support discovery and pipeline programs.

Responsibilities:

  • Perform conjugation (lysine, cysteine, site specific etc.) of antibodies to diverse linker-payloads on mg to gram scale, following established protocols and procedures.
  • Conduct purification of the antibody drug conjugates utilizing various chromatographic techniques (affinity chromatography, size exclusion chromatography, ion exchange chromatography, membrane filtration (TFF) etc.)
  • Perform analytical characterization of the antibodies and bioconjugates using analytical techniques including UV-Vis, HIC, SEC, RP-HPLC, and LC-MS.
  • Maintain accurate records of experiments, results and analytical data. Adhere to safety guidelines and protocols in the laboratory environment.

Qualifications:

  • Bachelor's or Master's degree in biochemistry or related discipline with 2+ years of industrial or academic experience in bioconjugation.
  • Hands on experience with conjugation, purification and analytical characterization of antibody drug conjugates.
  • Ability to work both independently & collaboratively and willingness to learn new bioconjugation chemistries/techniques.
  • Strong communication skills, collaborative, self-motivated, goal-oriented and strong teamwork in a fast-paced setting.

We are an Equal Opportunity Employer offering a competitive salary and benefits package. Applicants should be legally entitled to work for any employer in the US.

 

Bolt Biotherapeutics requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Bolt will consider requests for Reasonable Accommodations.

 

Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.

Similar Jobs

ZS Logo ZS

AI Engineering Specialist

Artificial Intelligence • Healthtech • Professional Services • Analytics • Consulting
Hybrid
6 Locations
13000 Employees
160K-170K Annually

Stepful Logo Stepful

Subject Matter Expert- Limited X-Ray Machine Operator

Artificial Intelligence • Edtech • Healthtech • Software
Remote or Hybrid
United States
115 Employees
35-40 Hourly

CrowdStrike Logo CrowdStrike

Business Systems Analyst

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
USA
10000 Employees

Snap Inc. Logo Snap Inc.

Systems Engineer

Artificial Intelligence • Cloud • Machine Learning • Mobile • Software • Virtual Reality • App development
Hybrid
Los Angeles, CA, USA
5000 Employees
133K-235K Annually
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: REDWOOD CITY, CA
93 Employees
Year Founded: 2015

What We Do

Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. Bolt’s technology is appropriate for a broad spectrum of antibodies targeting tumor antigens expressed on all types of cancer and therefore applicable to many types of patients, including those who are refractory to the current generation of checkpoint inhibitors. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, and its platform is based on technology exclusively licensed from Stanford University. The company is financed by world-class investors including Novo Holdings, Pivotal bioVenture Partners, Vivo Capital and Nan Fung Life Sciences. For more information about Bolt Biotherapeutics, please visit www.boltbio.com.

Similar Companies Hiring

Formation Bio Thumbnail
Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account